OrbiMed’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12M | Buy |
2,380,715
+132,466
| +6% | +$668K | 0.3% | 54 |
|
|
2025
Q1 | $14.6M | Sell |
2,248,249
-970,368
| -30% | -$6.29M | 0.35% | 51 |
|
|
2024
Q4 | $23.6M | Sell |
3,218,617
-354,383
| -10% | -$2.6M | 0.49% | 47 |
|
|
2024
Q3 | $26.8M | Buy |
3,573,000
+1,252,898
| +54% | +$9.38M | 0.49% | 52 |
|
|
2024
Q2 | $20.6M | Buy |
2,320,102
+1,680,102
| +263% | +$15M | 0.41% | 60 |
|
|
2024
Q1 | $6.48M | Buy |
640,000
+539,000
| +534% | +$5.46M | 0.12% | 92 |
|
|
2023
Q4 | $1.02M | Buy |
+101,000
| New | +$1.02M | 0.02% | 104 |
|